
Clinical highlights: Alzheimer’s disease
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company
The newsletter of this month is related to the relevance of eye tracking in Concussion
The newsletter of this month is related to the relevance of eye tracking in Deep Brain Stimulation (DBS) for Parkinson’s disease (PD).
The newsletter of this month is related to the analysis of eye movements for differential diagnosis of Multiple System Atrophy.
P3Lab receives ISO 13485:2016 certification for design and development of eye tracking devices
The newsletter of this month is related to the analysis of eye movements for the early diagnosis, differential diagnosis and follow-up of Parkinson’s disease.
P3Lab, a European Medtech startup active in the early diagnosis of Parkinson Syndrome based on eye tracking, raises 4.2 million
In today’s article, we shed light on the inspiration driving our mission, and share a few practical applications of eye tracking in the clinical practice. Hope you enjoy the read!
neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841
Centre Monnet – Av. Jean Monnet, 1 –
1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France
Our development is financed with
the support of the Walloon Region and the European Innovation Council
© Neuroclues 2022 – all rights reserved
Book a custom virtual walk-through of NeuroClues with one of our experts and see how our innovative eye-tracking technology could impact your clinical practice.